Evidence map›Paper›PMID 26162078›Full record

ArticlePloS one2015

Transcriptomic-Wide Discovery of Direct and Indirect HuR RNA Targets in Activated CD4+ T Cells.

Patsharaporn Techasintana, J Wade Davis, Matthew M Gubin, Joseph D Magee, Ulus Atasoy

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. HuR Regulates GATA3-Driven Type 2 Inflammation in CD4bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. HuR ablation destabilizesFrontiers in immunology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Cell cycle RNA regulons coordinating early lymphocyte development.Wiley interdisciplinary reviews. RNA · 2017
    Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Patsharaporn TechasintanaDepartment of Surgery, University of Missouri, Columbia, Missouri, United States of America; Department of Molecular Microbiology and Immunology, University of Missouri, Columbia, Missouri, United States of America.
J Wade DavisDepartment of Biostatistics, University of Missouri, Columbia, Missouri, United States of America.
Matthew M GubinDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, United States of America.
Joseph D MageeDalton Cardiovascular Research Center, University of Missouri, Columbia, Missouri, United States of America.
Ulus AtasoyDepartment of Surgery, University of Missouri, Columbia, Missouri, United States of America; Department of Molecular Microbiology and Immunology, University of Missouri, Columbia, Missouri, United States of America.
University of Missouri · USWashington University in St. Louis · US

Funding

HuR in Allergic Asthma and T Cell DifferentiationR01AI080870 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI ATASOY, ULUS · 2009 to 2019
$3.6M
Posttranscriptional Gene Regulation in AsthmaR21AI079341 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI ATASOY, ULUS · 2009 to 2010
$381k
NIAID NIH HHS 2R01AI080870-05A1NIAID NIH HHS R01 AI080870NIAID NIH HHS R01AI080870NIAID NIH HHS R21 AI079341NIAID NIH HHS R21AI079341
6 · The paper itself

Abstract

Due to poor correlation between steady state mRNA levels and protein product, purely transcriptomic profiling methods may miss genes posttranscriptionally regulated by RNA binding proteins (RBPs) and microRNAs (miRNAs). RNA immunoprecipitation (RIP) methods developed to identify in vivo targets of RBPs have greatly elucidated those mRNAs which may be regulated via transcript stability and translation. The RBP HuR (ELAVL1) and family members are major stabilizers of mRNA. Many labs have identified HuR mRNA targets; however, many of these analyses have been performed in cell lines and oftentimes are not independent biological replicates. Little is known about how HuR target mRNAs behave in conditional knock-out models. In the present work, we performed HuR RIP-Seq and RNA-Seq to investigate HuR direct and indirect targets using a novel conditional knock-out model of HuR genetic ablation during CD4+ T activation and Th2 differentiation. Using independent biological replicates, we generated a high coverage RIP-Seq data set (>160 million reads) that was analyzed using bioinformatics methods specifically designed to find direct mRNA targets in RIP-Seq data. Simultaneously, another set of independent biological replicates were sequenced by RNA-Seq (>425 million reads) to identify indirect HuR targets. These direct and indirect targets were combined to determine canonical pathways in CD4+ T cell activation and differentiation for which HuR plays an important role. We show that HuR may regulate genes in multiple canonical pathways involved in T cell activation especially the CD28 family signaling pathway. These data provide insights into potential HuR-regulated genes during T cell activation and immune mechanisms.

Indexed as

Gene Expression RegulationLymphocyte ActivationTranscriptomeAnimalsCD28 AntigensCD4-Positive T-LymphocytesCell DifferentiationCells, CulturedELAV-Like Protein 1HumansMiceMice, Inbred C57BLMice, KnockoutRNA, MessengerTh2 CellsCD28 AntigensELAV-Like Protein 1RNA, Messenger

Identifiers

PMID26162078
PMCPMC4498740
OpenAlexW1497424392

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.